載入...
In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy
Oral delivery of proteins is still a challenge in the pharmaceutical field. Nanoparticles are among the most promising carrier systems for the oral delivery of proteins by increasing their oral bioavailability. However, most of the existent data regarding nanosystems for oral protein delivery is fro...
Na minha lista:
| 發表在: | Nanoscale |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Royal Society of Chemistry
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5047059/ https://ncbi.nlm.nih.gov/pubmed/27150301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c6nr00294c |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|